35
Views
13
CrossRef citations to date
0
Altmetric
Original Article

Therapeutic Angiogenesis for Treatment of Peripheral Vascular Disease

, , &
Pages 269-279 | Received 01 Apr 2004, Published online: 07 Aug 2009

References

  • Al-Khaldi, A., Al-Sabti, H., Galipeau, J. and Lachapelle, K. (2003) "Therapeutic angiogenesis using autologous bone marrow stromal cells: improved blood flow in a chronic limb ischemia model", Ann. Thorac. Surg. 75, 204–209.
  • Arsic, N., Zentilin, L., Zacchigna, S., Santoro, D., Stanta, G., Salvi, A., Sinagra, G. and Giacca, M. (2003) "Induction of functional neovascularization by combined VEGF and angiopoietin-gene transfer using AAV vectors", Mol. Ther. 7, 450–459.
  • Asahara, T., Bauters, C., Zheng, L.P. Takeshita, S., Bunting, S., Ferrara, N., Symes, J.F. and Isner, J.M. (1995) "Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo", Circulation 92, II365-II371.
  • Baffour, R., Berman, J., Garb, J.L. Rhee, S.W. Kaufman, J. and Friedmann, P. (1992) "Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: dose-response effect of basic fibroblast growth factor", J. Vasc. Surg. 16, 181–191.
  • Baffour, R., Garb, J.L. Kaufman, J., Berman, J., Rhee, S.W. Norris, M.A. and Friedmann, P. (2000) "Angiogenic therapy for the chronically ischemic lower limb in a rabbit model", J. Surg. Res. 93, 219–229.
  • Barr, E. and Leiden, J.M. (1991) "Systemic delivery of recombinant proteins by genetically modified myoblast", Science 254, 1507–1509.
  • Baumgartner, I. (2000) "Therapeutic angiogenesis: theoretic problems using vascular endothelial growth factor", Curr. Cardiol. Rep. 2, 24–28.
  • Baumgartner, I., Pieczek, A., Manor, O., Blair, R., Kearney, M., Walsh, K. and Isner, J.M. (1998) "Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia", Circulation 97, 1114–1123.
  • Bauters, C., Asahara, T., Zheng, L.P. Takeshita, S., Bunting, S., Ferrara, N., Symes, J.F. and Isner, J.M. (1994) "Physiological assessment of augmented vascularity induced by VEGF in ischemic rabbit hindlimb", Am. J. Physiol. 267, H1263-H1271.
  • Bauters, C., Asahara, T., Zheng, L.P. Takeshita, S., Bunting, S., Ferrara, N., Symes, J.F. and Isner, J.M. (1995) "Recovery of distrurbed endothelium-dependent flow in the collateral-perfused rabbit ischemic hind limb after administration of vascular endothelial growth factor", Circulation 91, 2802–2809.
  • Beauchamp, J.R. Morgan, J.E. Pagel, C.N. and Partridge, T.A. (1994) "Quantitative studies of the efficacy of myoblast transplantation", Muscle Nerve 18, S261.
  • Blau, H.M. and Rossi, F.M. (1999) "Tet B or not Tet B: advances in tetracycline-inducible gene expression", Proc. Natl Acad. Sci. USA 96, 797–799.
  • Bohl, D., Naffakh, N. and Heard, J.M. (1997) "Long-term control of erythropoietin secretion by doxycycline in mice transplanted with engineered primary myoblast", Nat. Med. 3, 299–305.
  • Cao, R., Brakenhielm, E., Pawliuk, R., Wariaro, D., Post, M.J. Wahlberg, E., Leboulch, P. and Cao, Y. (2003) "Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2", Nat. Med. 9, 604–613.
  • Carmeliet, P. (1999) "Basic concepts of (myocardial) angiogenesis: role of vascular endothelial growth factor and angiopoietin", Curr. Interv. Cardiol. Rep. 1, 322–335.
  • Carmeliet, P. (2000) "Mechanisms of angiogenesis and arteriogenesis", Nat. Med. 6, 389–395.
  • Carmeliet, P. and Collen, D. (1999) "Role of vascular endothelial growth factor and vascular endothelial growth factor receptors in vascular development", Curr. Top Microbiol. Immunol. 237, 133–158.
  • Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., Declercq, C., Pawling, J., Moons, L., Collen, D., Risau, W. and Nagy, A. (1996) "Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele", Nature 380, 435–439.
  • Caron, N.J. Asselin, I., Morel, G. and Tremblay, J.P. (1999) "Increased myogenic potential and fusion of matrilysin-expressing myoblast transplanted in mice", Cell Transplant. 8, 465–476.
  • Chae, J.K. Kim, J., Lim, S.T. Chung, M.J. Kim, W.H. Kim, H.G. Ko, J.K. and Koh, G.Y. (2000) "Coadministration of angiopoietin-1 and vascular endothelial growth factor enhances collateral vascularization", Arterioscler. Thromb. Vasc. Biol. 20, 2573–2578.
  • Chang, D.S. Su, H., Tang, G.L. Brevetti, L.S. Sarkar, R., Wang, R., Kan, Y.W. and Messina, L.M. (2003) "Adeno-associated viral vector-mediated gene transfer of VEGF normalizes skeletal muscle oxygen tension and induces arteriogenesis in ischemic rat hindlimb", Mol. Ther. 7, 44–51.
  • Cheng, J.M. Lin, C.M. Lin, C.L. Huang, S.M. Chang, H.L. Lee, C.C. Chiang, L.C. and Chang, P.Y. (2000) "Effects of VEGF121 and/or VEGF165 gene transfection on collateral circulation development", J. Formos. Med. Assoc. 99, 603–611.
  • Chleboun, J.O. and Martins, R.N. (1994) "The development and enhancement of the collateral circulation in an animal model of lower limb ischemia", Aust. N. Z. J. Surg. 64, 202–207.
  • Chleboun, J.O. Martins, R.N. Mitchell, C.A. and Chirila, T.V. (1992) "bFGF enhances the development of the collateral circulation after acute arterial occlusion", Biochem. Biophys. Res. Commun. 185, 510–516.
  • Crystal, R.G. (1997) "Phase I study of direct administration of a replication deficient adenovirus vector containing, E coli cytosine deaminase gene to metastatic colon carcinoma of the liver in association with the pro-drug 5-fluorocytosine", Hum. Gene. Ther. 8, 985–1001.
  • Dai, Y., Roman, M., Naviaux, R.K. and Verma, I.M. (1992) "Gene therapy via primary myoblast: long-term expression of factor IX protein following transplantation in vivo", Proc. Natl Acad. Sci. USA 89, 10892–10895.
  • Davis, S., Aldrich, T.H. Jones, P.F. Acheson, A., Compton, D.L. Jain, V., Ryan, T.E. Bruno, J., Radziejewski, C., Maisonpierre, P.C. and Yancopoulos, G.D. (1996) "Isolation of angiopoietin-1, a ligand for the Tie2 receptor, by secretion-trap expression cloning", Cell 87, 1161–1169.
  • Dhawan, J., Pan, L.C. Pavlath, G.K. Travis, M.A. Lanctot, A.M. and Blau, H.M. (1991) "Systemic delivery of human growth hormone by injection of genetically engineered myoblast", Science 254, 1509–1512.
  • Dvorak, H.F. Nagy, J.A. Feng, D., Brown, L.F. and Dvoral, A.M. (1999) "Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angio-genesis", Curr. Top. Microbiol. Immunol. 237, 97–132.
  • El-Fahime, E., Torrente, Y., Caron, N., Bresolin, M. and Tremblay, J.P. (2000) "In vivo migration of transplanted myoblast requires matrix metalloproteinase activity", Exp. Cell Res. 258, 279–287.
  • Eriksson, U. and Alitalo, K. (1999) "Structure, expression and receptor-binding properties of novel vascular endothelial growth factors", Curr. Top. Microbiol. Immunol. 237, 41–57.
  • Felgner, P.L. Gadek, T.R. Holm, M., Roman, R., Chan, H.W. Wenz, M., Northrop, J.P. Ringold, G.M. and Danielsen, M. (1987) "Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure", Proc. Natl Acad. Sci. USA 84, 7413–7417.
  • Ferrara, N. (1999) "Vascular endothelial growth factor: Molecular and biological aspects", Curr. Top. Microbiol. Immunol. 237, 1–30.
  • Ferrara, N. and Henzel, W.J. (1989) "Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells", Biochem. Biophys. Res. Commun. 161, 851–858.
  • Ferrara, N., Leung, D.W. Cachianes, G., Winer, J. and Henzel, W.J. (1991) "Purification and cloning of vascular endothelial growth factor secreted by folliculo-stellate cells", Methods Enzymol. 198, 391–405.
  • Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K.S. Powell-Braxton, L., Hillan, K.J. and Moore, M.W. (1996) "Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene", Nature 380, 439–442.
  • Fong, G-H., Rossant, J., Gersenstein, M. and Breitman, M.L. (1995) "Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium", Nature 376, 66–70.
  • Fox, J.C. and Swain, J.L. (1996) "Angiogenic gene therapy. A leg to stand on?", Circulation 94, 3065–3066.
  • Gale, N.W. and Yancopoulos, G.D. (1999) "Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angio-poietins, and ephrins in vascular development", Genes Dev. 13, 1055–1066.
  • Gerber, H.P. Hillan, K.J. Ryan, A.M. Kowalski, J., Keller, G.A. Rangell, L., Wright, B.D. Radtke, F., Aguet, M. and Ferrara, N. (1999a) "VEGF is required for growth and survival in neonatal mice", Development 126, 1149–1159.
  • Gerber, H.P. Vu, T.H. Ryan, A.M. Kowalski, J., Wreb, Z. and Ferrara, N. (1999b) "VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation", Nat. Med. 5, 623–628.
  • Gilgenkrantz, H., Duboc, D., Juillard, V., Couton, D., Pavirani, A., Guillet, J.G. Briand, P. and Kahn, A. (1995) "Transient expression of genes transferred in vivo into heart using first-generation adenoviral vectors: role of the immune response", Hum. Gene. Ther. 6, 1265–1274.
  • Goede, V., Schmidt, T., Kimmina, S., Kozian, D. and Augustin, H.G. (1998) "Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis", Lab. Invest. 78, 1385–1394.
  • Gowdak, L.H. Poliakova, L., Li, Z., Grove, R., Lakatta, E.G. and Talan, M. (2000a) "Induction of angiogenesis by cationic lipid-mediated VEGF165 gene transfer in the rabbit ischemic hindlimb model", J. Vasc. Surg. 32, 343–352.
  • Gowdak, L.H. Poliakova, L., Wang, X., Kovesdi, I., Fishbein, K.W. Zacheo, A., Palumbo, R., Straino, S., Emanueli, C., Marrocco-Trischitta, M., Lakatta, E.G. Anversa, P., Spencer, R.G. Talan, M. and Capogrossi, M.C. (2000b) "Adenovirus-mediated VEGF(121) gene transfer stimulates angiogenesis in normoperfused skeletal muscle and preserves tissue perfusion after induction of ischemia", Circulation 102, 565–571.
  • Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., Le Deist, F., Wulffraat, N., Mcintyre, E., Radford, I., Villeval, J.L. Fraser, C.C. Cavazzana-Calvo, M. and Fischer, A. (2003) "A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency", N. Engl. J. Med. 348, 255–256.
  • Hamamori, Y., Samal, B., Tian, J. and Kedes, L. (1994) "Persistent erythropoiesis by myolablast transfer of erythropoietin cDNA", Hum. Gene. Ther. 5, 1349–1356.
  • Hamamori, Y., Samal, B., Tian, J. and Kedes, L. (1995) "Myoblast transfer of human erythropoietin gene in a mouse model of renal failure", J. Clin. Invest. 95, 1808–1813.
  • Hamano, K., Li, T.S. Kobayashi, T., Tanaka, N., Kobayashi, S., Matsuzaki, M. and Esato, K. (2001) "The induction of angiogenesis by the implantation of autologous bone marrow cells: a novel and simple therapeutic method", Surgery 130, 44–54.
  • Hayashi, S., Morishita, R., Nakamura, S., Yamamoto, K., Moriguchi, A., Nagano, T., Taiji, M., Noguchi, H., Matsumoto, K., Nakamura, T., Higaki, J. and Ogihara, T. (1999) "Potential role of hepatocyte growth factor, a novel angiogenic growth factor, in peripheral arterial disease: down regulation of HGF in response to hypoxia in vascular cells", Circulation 100, II301 -II308.
  • Hellstrom, M., Kaln, M., Lindahl, P., Abramsson, A. and Betsholtz, C. (1999) "Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth cells and pericytes during embryonic blood vessel formation in the mouse", Development 126, 3047–3055.
  • Hershey, J.C. Baskin, E.P. Corcoran, H.A. Bett, A., Dougherty, N.M. Gilberto, D.B. Mao, X., Thomas, K.A. and Cook, J.J. (2003) "Vascular endothelial growth factor stimulates angiogenesis without improving collateral blood flow following hindlimb ischemia in rabbits", Heart Vessels 18, 142–149.
  • Hirakata, K., Li, T.S. Nishida, M., Ito, H., Matsuzaki, M., Kasaoka, S. and Hamano, K. (2003) "Autologous bone marrow cell implantation as therapeutic angiogenesis for ischemic hindlimb in diabetic rat model", Am. J. Physiol. Heart Circ. Physiol. 284, H66-H70.
  • Hirschi, K.K. Rohovsky, S.A. Beck, L.H. Smith, S.R. and D'Amore, P.A. (1999) "Endothelial cells modulate the proliferation of mural cell precursors via platelet-derived growth factor-BB and heterotypic cell contact", Circ. Res. 84, 298–305.
  • Hopkins, S.P. Bilgrin, J.P. Sims, R.L. Bowman, B., Donovan, D.L. and Schmidt, S.P. (1998) "Controlled delivery of vascular endothelial growth factor promotes neovascularization and maintains limb function in a rabbit model ofischemia", J. Vasc. Surg. 275, 886–894.
  • Huang, Y.Q. Li, J.J. and Karpatkin, S. (2000) "Identification of a family of alternatively spliced mRNA species of angiopoietin-1", Blood 95, 1993–1999.
  • Huard, J., Ascadi, G., Jani, A., Massie, B. and Karpati, G. (1994) "Gene transfer into skeletal muscles by isogenic myoblast", Hum. Gene. Ther. 5, 949–958.
  • Iba, O., Matsubara, H., Nozawa, Y., Fujiyama, S., Amano, K., Mori, Y., Kojima, H. and Iwasaka, T. (2002) "Angiogenesis by implantation of peripheral blood mononuclear cells and platelets into ischemic limbs", Circulation 106, 2019–2025.
  • Ikenaga, S., Hamano, K., Nishida, M., Kobayashi, T., Li, T.S. Kobayashi, S., Matsuzaki, M., Zempo, N. and Esato, K. (2001) "Autologous bone marrow implantation induced angiogenesis and improved deteriorated exercise capacity in a rat ischemic hindlimb model", J. Surg. Res. 96, 277–283.
  • Isner, J.M. (1998) "Vascular endothelial growth factor: gene therapy and therapeutic angiogenesis", Am. J. Cardiol. 82, 63S -64S.
  • Isner, J.M. Pieczek, A., Schainfeld, R., Blair, R., Haley, L., Asahara, T., Rosenfield, K., Razvi, S., Walsh, K. and Symes, J.F. (1996a) "Clinical evidence of angiogenesis after arterial gene transfer of phVEGF 165 in patient with ischemic limb", Lancet 348, 370–374.
  • Isner, J.M. Walsh, K., Symes, J., Pieczek, A., Takeshita, S., Lowry, J., Rosenfield, K., Weir, L., Brogi, E. and Jurayj, D. (1996b) "Arterial gene transfer for therapeutic angiogenesis in patients with peripheral artery disease", Hum. Gene. Ther. 7, 959–988.
  • Ito, H., Hallauer, P.L. Hastings, K.E. and Tremblay, J.P. (1998) "Prior culture with concanavalin A increases intramuscular migration of transplanted myoblast", Muscle Nerve 21, 291–297.
  • Iwama, A., Hamaguchi, I., Hashiyama, M., Mutayama, Y., Yasunaga, K. and Suda, T. (1993) "Molecular cloning and characterization of mouse Tie and Tek receptor tyrosine kinase genes and their expression in hematopoietic stem cells", Biochem. Biophys. Res. Commun. 195, 301–309.
  • Kim, I., Moon, S.O. Koh, K.N. Kim, H., Uhrn, C.S. Kwak, H.J. Kim, N.G. and Koh, G.Y. (1999) "Molecular cloning, expression, and characterization of angiopoietin-related protein", J. Biol. Chem. 274, 26523–26528.
  • Kim, I., Kim, H.G. Moon, S.O. Chae, S.W. So, J.N. Koh, K.N. Ahn, B.C. and Koh, G.Y. (2000a) "Angiopoietin-1 induces endothelial cell sprouting through the activation of focal adhesion kinase and plasmin secretion", Circ. Res. 86, 952–959.
  • Kim, I., Kim, H.G. So, J.N. Kim, J.H. Kwak, H.J. and Koh, G.Y. (2000b) "Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway", Circ. Res. 86, 24–29.
  • Kinoshita, I., Vilquin, J.T. Guerette, B.G. Asselin, I. and Tremblay, J.P. (1994) "Very efficient myoblast transplantation in mice under FK506 immunosuppression", Muscle Nerve 17, 1407–1415.
  • Kinoshita, I., Vilquin, J.T. and Tremblay, J.P. (1995) "Pretreatment of myoblast cultures with basic fibroblast growth factor increases the efficacy of their transplantation in mdx mice", Muscle Nerve 18, 834–841.
  • Kinoshita, I., Roy, R., Dugre, F.J. Gravel, C., Roy, B., Goulet, M., Asselin, I. and Tremblay, J.P. (1996a) "Myoblast transplantation in monkeys: control of immune response by FK506", J. Neuropathol. Exp. Neurol. 55, 687–697.
  • Kinoshita, I., Vilquin, J.T. Roy, T. and Tremblay, J.P. (1996b) "Successive injections in mdx mice of myoblast grown with bFGF", Neuromuscul. Disord. 6, 187–193.
  • Koblizek, T.I. Weiss, C., Yancopoulos, G.D. Deutsch, U. and Risau, W. (1998) "Angiopoietin-1 induces sprouting angiogenesis in vitro", Curr. Biol. 8, 529–532.
  • Korhonen, J., Polvi, A., Partanen, J. and Alitalo, K. (1994) "The mouse Tie receptor tyrosine kinase gene: expression during embryonic angiogenesis", Oncogene 9, 395–403.
  • Kringstein, A.M. Rossi, F.M. Hofmann, A. and Blau, H.M. (1998) "Graded transcriptional response to different concentration of a single transactivator", Proc. Natl Acad. Sci. USA 95, 13670–13675.
  • Kyriakides, Z.S. Petinakis, P., Kaklamanis, L., Sbarouni, E., Karayannakos, P., Iliopoulos, D., Dontas, I. and Kremastinos, D.T. (2001) "Intramuscular administration of estrogen may promote angiogenesis and perfusion in a rabbit model of chronic limb ischemia", Cardiovasc. Res. 49, 626–633.
  • Lazarous, D.F. Unger, E.F. Epstein, S.E. Stine, A., Arevalo, J.L. Chew, E.Y. and Quyyumi, A.A. (2000) "Basic Fibroblast Growth Factor in Patients With Intermittent Claudication: Results of a Phase I Trial", J.Am. Coll. Cardiol. 36, 1239–1244.
  • Lederman, R.J. Mendelsohn, F.O. Anderson, R.D. Saucedo, J.F. Tenaglia, A.N. Hermiller, J.B. Hillegass, W.B. Rocha-Singh, K., Moon, T.E. Whitehouse, M.J. and Annex, B.H. (2002) "Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial", Lancet 359, 2053–2058.
  • Lee, R.J. Springer, M.L. Blanco-Bose, W., Shaw, R., Ursell, P.C. and Blau, H. (2000) "VEGF gene delivery to myocardium: deleterious effects of unregulated expression", Circulation 102, 898–901.
  • Lefaucheur, J.P. and Sebille, A. (1995) "Basic fibroblast growth factor promotes in vivo muscle regeneration in murine muscular dystrophy", Neurosci. Lett. 202, 121–124.
  • Lefaucheur, J.P. Gjata, B., Lafont, H. and Sebille, A. (1996) "Angiogenic and inflammatory responses following skeletal muscle injury are altered by immune neutralization of endogenous basic fibroblast growth factor, insulin-like growth factor-I and transforming growth factor-1", J. Neuroimmunol. 70, 37–44.
  • Leiden, J.M. (2000) "Human gene therapy. The good, the bad, and the ugly", Circ. Res. 86, 923–925.
  • Lochmuller, H., Petrof, B.J. Pari, G., Larochelle, N., Dodelet, V., Wang, Q., Allen, C., Prescott, S., Massie, B., Nalbantoghu, J. and Karpati, G. (1996) "Transient immunosuppression by FK506 permits a sustained high-level dystrophin expression after adenovirus-mediated dystro-phin minigene transfer to skeletal muscles of adult dystrophic (mdx) mice", Gene. Ther. 3, 706–716.
  • Lu, Y., Shansky, J., Tatto, M.D. Ferland, P., Wang, X. and Vandenburgh, H. (2001) "Recombinant vascular endothelial growth factor secreted from tissue-engineered bioartificial muscle promotes localized angiogenesis", Circulation 104, 594–599.
  • Maisonpierre, P.C. Suri, C., Jones, P.F. Bartunkova, S., Wiegand, S.J. Radziejewski, C., Compton, D., McClain, J., Aldrich, T.H. Papadopoulos, N., Daly, T.J. Davis, S., Sato, T.N. and Yancopoulos, G.D. (1997) "Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis", Science 277, 55–60.
  • Masaki, I., Yonemitsu, Y., Yamashita, A., Sata, S., Tanii, M., Komori, K., Nakagawa, K., Hou, X., Nagai, Y., Hasegawa, M., Sugimachi, K. and Sueishi, K. (2002) "Angiogenic gene therapy for experimental critical limb ischemia: acceleration of limb loss by overexpression of vascular endothelial growth factor 165 but not of fibroblast growth factor-2", Circ. Res. 90, 966–973.
  • Melillo, G., Scoccianti, M., Kovesdi, I., Safi, J., Jr., Riccioni, T. and Capogrossi, M.C. (1997) "Gene therapy for collateral vessel development", Cardiovasc. Res. 35, 480–489.
  • Milia, A.F. Salis, M.B. Stacca, T., Pinna, A., Madeddu, P., Trevisani, M., Geppetti, P. and Emanueli, C. (2002) "Protease-activated receptor-2 stimulates angiogenesis and accelerates hemo-dynamic recovery in a mouse model of hindlimb ischemia", Circ. Res. 91, 346–352.
  • Montesano, R., Vassalli, J.D. Baird, A., Guillemin, R. and Orci, L. (1986) "Basic fibroblast growth factor induces angiogenesis in vitro", Proc. Natl Acad. Sci. USA 83, 7297–7301.
  • Morishita, R., Sakaki, M., Yamamoto, K., Iguchi, S., Aoki, M., Yamasaki, K., Matsumoto, K., Nakamura, T., Lawn, R., Ogihara, T. and Kaneda, Y. (2002) "Impairment of collateral formation in lipoprotein(a) transgenic mice: therapeutic angiogenesis induced by human hepatocyte growth factor gene", Circulation 105, 1491–1496.
  • Muhlhauser, J., Jones, M., Yamada, I., Cirielli, C., Lemarchand, P., Gloe, T.R. Bewig, B., Signoretti, S., Crystal, R.G. and Capogrossi, M.C. (1996) "Safety and efficacy of in vivo gene transfer into the porcine heart with replication-deficient, recombinant adenovirus vectors", Gene. Ther. 3, 145–153.
  • Nabel, E.G. (2002) "Stem cells combined with gene transfer for therapeutic vasculogenesis: magic bullets?", Circulation 105, 672–674.
  • Neufeld, G., Cohen, T., Gengrinovitch, S. and Poltorak, I. (1999) "Vascular endothelial growth factor (VEGF) and its receptors", FASEB J. 13, 9–22.
  • Neumeister, M.W. Song, Y.-H., Mowlavi, A., Suchy, H. and Mathur, A. (2001) "Effects of liposome-mediated gene transfer of VEGF in ischemic rat gracilis muscle", Microsurgery 21, 58–62.
  • Ohara, N., Koyama, H., Miyata, T., Hamada, H., Miyatake, S.I. Akimoto, M. and Shigematsu, H. (2001) "Adenovirus-mediated ex vivo gene transfer of basic fibroblast growth factor promotes collateral development in a rabbit model of hind limb ischemia", Gene. Ther. 8, 837–845.
  • Onimaru, M., Yonemitsu, Y., Tanii, M., Nakagawa, K., Masaki, I., Okano, S., Ishibashi, H., Shirasuna, K., Hasegawa, M. and Sueishi, K. (2002) "Fibroblast growth factor-2 gene transfer can stimulate hepatocyte growth factor expression irrespective of hypoxia-mediated downregulation in ischemic limbs", Circ. Res. 91, 923–930.
  • Papapetropoulos, A., Garcia-Cardena, G., Dengler, T.J. Maisonpierre, P.C. Yancopoulos, G.D. and Sessa, W.C. (1999) "Direct actions of angiopoietin-1 on human endothelium: evidence for network stabilization, cell survival and interaction with other angiogenic growth factors", Lab. Invest. 79, 213–223.
  • Procopio, W.N. Pelavin, P.I. Lee, W.M.F. and Yeilding, N.M. (1999) "Angiopoietin-1 and -2 coiled-coil domains mediate distinct homo-oligomerization patterns, but fibrinogen-like domains mediate ligand activity", J. Biol. Chem. 277, 30196–30201.
  • Qu, Z. and Huard, J. (2000) "Matching host muscle and donor myoblast for myosin heavy chain improves myoblast transfer therapy", Gene. Ther. 7, 428–437.
  • Rando, T.A. and Blau, H.M. (1994) "Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy", J. Cell. Biol. 125, 1275–1287.
  • Rissanen, T.T. Markkanen, J.E. Arve, K., Rutanen, J., Kettunen, M.I. Vajanto, I., Jauhiainen, S., Cashion, L., Gruchala, M., Narvanen, O., Taipale, P., Kauppinen, R.A. Rubanyi, G.M. and Yla-Herttuala, S. (2003) "Fibroblast growth factor 4 induces vascular permeability, angiogenesis and arteriogenesis in a rabbit hindlimb ischemia model", FASEB, J 17, 100–102.
  • Robinson, C.J. and Stringer, S.E. (2001) "The splice variants of vascular endothelial growth factor (VEGF) and their receptors", J. Cell Sci. 114, 853–865.
  • Sato, T.N. Qin, Y., Kozak, C.A. and Audus, K.L. (1993) "Tie-1 and Tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system", Proc. Natl Acad. Sci. USA 90, 9355–9358.
  • Sato, T.N. Tozawa, Y., Deutsch, U., Wolburg-Bucholz, K., Fujiwara, Y., Gendron-Maguire, M., Gridley, T., Wolburg, H., Risau, W. and Qin, Y. (1995) "Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation", Nature 376, 70–74.
  • Schainfeld, R.M. and Isner, J.M. (1999) "Critical limb ischemia: nothing to give at the office?", Ann. Intern. Med. 130, 442–444.
  • Shalaby, F., Rossant, J., Yamaguchi, T.P. Gertsenstein, M., Wu, X.F. Breitman, M.L. and Schuh, A.C. (1995) "Failure of blood island formation and vasculogenesis in Flk-1-deficient mice", Nature 367, 62–66.
  • Shibuya, M., Yamaguchi, S., Yamane, A., Ikeda, T., Tojo, A., Matsushime, H. and Sato, M. (1990) "Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family", Oncogene 5, 519–524.
  • Shimpo, M., Ikeda, U., Maeda, Y., Takahashi, M., Miyashita, H., Mizukami, H., Urabe, M., Kume, A., Takizawa, T., Shibuya, M., Ozawa, K. and Shimada, K. (2002) "AAV-mediated VEGF gene transfer into skeletal muscle stimulates angiogenesis and improves blood flow in a rat hindlimb ischemia model", Cardiovasc. Res. 53, 993–1001.
  • Shyu, K.G. Chang, H. and Isner, J.M. (2003a) "Synergistic effect of angiopoitein-1 and vascular endothelial growth factor on neoangio-genesis in hypercholesterolemic rabbit model with acute hindlimb ischemia", Life Sci. 73, 563–579.
  • Shyu, K.G. Chang, H., Wang, B.W. and Kuan, P. (2003b) "Intramuscular vascular endothelial growth factor gene therapy in patients with chronic critical leg ischemia", Am. J. Med. 114, 85–92.
  • Silvestre, J.S. and Levy, B.I. (2002) "Angiogenesis therapy in ischemic disease", Arch. Mal. Coeur Vaiss. 95, 189–196.
  • Smythe, G.M. and Grounds, M.D. (2000) "Exposure to tissue culture conditions can adversely affect myoblast behaviors in vivo in whole muscle grafts: implications for myoblast transfer therapy", Cell Transplant 9(3), 379–393.
  • Smythe, G.M. and Grounds, M.D. (2001) "Absence of MyoD increases donor myoblast migration into host muscle", Exp. Cell Res. 267, 267–274.
  • Smythe, G.M. Lai, M.C. Grounds, M.D. and Rakoczy, P.E. (2002) "Adeno-associated virus-mediated vascular endothelial growth factor gene therapy in skeletal muscle before transplantation promotes revascularization of regenerating muscle", Tissue Eng. 8, 879–891.
  • Springer, M.L. Chen, A.S. Kraft, P.E. Bednarski, M. and Blau, H. (1998) "VEGF gene delivery to muscle: potential role for vasculogenesis in adults", Mol. Cell 2, 549–558.
  • Springer, M.L. Ozawa, C.R. Banfi, A., Kraft, P.E. Ip, T.K. Brazelton, T.R. and Blau, H.M. (2003) "Localized arteriole formation directly adjacent to site ofVEGF-induced angiogenesis in muscle", Mol. Ther. 7, 441–449.
  • Suri, C., Jones, P.F. Patan, S., Bartunkova, S., Maisonpierre, P.C. Davis, S., Sato, T.N. and Yancopoulos, G.D. (1996) "Requisite role of Angiopoietin-1, a ligand for the Tie2 receptor, during embryonic angiogenesis", Cell 87, 1171–1180.
  • Suzuki, K., Murtuza, B., Smolenski, R.T. Sammut, L.A. Suzuki, N., Kaneda, Y. and Yacoub, M.H. (2001) "Cell transplantation for the treatment of acute myocardial infarction using VEGF-expressing skeletal myoblast", Circulation 104, I207-I212.
  • Takeshita, S., Pu, L.Q. Stein, L.A. Sniderman, A.D. Bunting, S., Ferrara, N., Isner, J.M. and Symes, J.F. (1994a) "Intramuscular administration of vascular endothelial growth factor induces dose-dependent collateral artery augmentation in a rabbit model of chronic limb ischemia", Circulation 90, II228-II234.
  • Takeshita, S., Zheng, L.P. Brogi, E., Kearney, M., Pu, L.-Q., Bunting, S., Ferrara, N., Symes, J.F. and Isner, J.M. (1994b) "Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model", J. Clin. Invest. 93(6), 62–670.
  • Takeshita, S., Rossow, S.T. Kearney, M., Zheng, L.P. Bauters, C., Bunting, S., Ferrara, N., Symes, J.F. and Isner, J.M. (1995) "Time course of increased cellular proliferation in collateral arteries after administration of vascular endothelial growth factor in a rabbit model of lower limb vascular insufficiency", Am. J. Pathol. 147, 1649–1660.
  • Takeshita, S., Weir, L., Chen, D., Zheng, L.P. Riessen, R., Bauters, C., Symes, J.F. Ferrara, N. and Isner, J.M. (1996) "Therapeutic angiogenesis following arterial gene transfer of vascular endothelial growth factor in a rabbit model of hindlimb ischemia", Biochem. Biophys. Res. Commun. 227, 628–635.
  • Takeshita, S., Isshiki, T., Ochiai, M., Eto, K., Mori, H., Tanaka, E., Umetani, K. and Sato, T. (1998) "Endothelium-dependent relaxation of collateral microvessels after intramuscular gene transfer of vascular endothelial growth factor in a rat model of hindlimb ischemia", Circulation 98, 1261–1263.
  • Taniyama, Y., Morishita, R., Aoki, M., Nakagami, H., Yamamoto, K., Yamazaki, K., Matsumoto, K., Nakamura, T., Kaneda, Y. and Ogihara, T. (2001) "Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hind limb ischemia models: preclinical study for treatment of peripheral arterial disease", Gene. Ther. 8, 181–189.
  • Terman, B.I. Dougher-Vermazen, M., Carrion, M.E. Dimitrov, D., Armellino, D.C. Gospodarowicz, D. and Bohlen, P. (1992) "Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor", Biochem. Biophy. Res. Commun. 187, 1579–1586.
  • Thurston, G., Suri, C., Smith, K., McClain, J., Sato, T.N. Yancopoulos, G.D. and McDonald, D.M. (1999) "Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1", Science 286, 2511–2514.
  • Thurston, G., Rudge, J.S. Ioffe, E., Zhou, H., Ross, L., Croll, S.D. Glazer, N., Holash, J., McDonald, D.M. and Yancopoulos, G.D. (2000) "Angiopoietin-1 protects the adult vasculature against plasma leakage", Nat. Med. 6, 460–463.
  • Torrente, Y., El Fahime, E., Caron, N.J. Bresolin, N. and Tremblay, J.P. (2000) "Intramuscular migration of myoblast transplanted after muscle pretreatment with metalloproteinases", Cell. Transplant. 9, 539–550.
  • Tsurumi, Y., Takeshita, S., Chen, D., Kearney, M., Rossow, S.T. Passeri, J., Horowitz, J.R. Symes, J.F. and Isner, J.M. (1996) "Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion", Circulation 94, 3281–3290.
  • Tsurumi, Y., Kearney, M., Chen, D., Silver, M., Takeshita, S., Yang, J., Symes, J.F. and Isner, J.M. (1997) "Treatment of acute limb ischemia by intramuscular injection of vascular endothelial growth factor gene", Circulation 96, II382-II388.
  • Vale, P.R. Isner, J.M. and Rosenfield, K. (2001) "Therapeutic angiogenesis in critical limb and myocardial ischemia", J. Interv. Cardiol. 14, 511–528.
  • Verma, I.M. (2000) "A tumultuous year for gene therapy", Mol. Ther. 2, 415–416.
  • Vincent, K.A. Shyu, K.G. Luo, Y., Magner, M., Tio, R.A. Jiang, C., Goldberg, M.A. Akita, G.Y. Gregory, R.J. and Isner, J.M. (2000) "Angiogenesis is induced in a rabbit model of hindlimb ischemia by naked DNA encoding an HIF-1alpha/VP16 hybrid transcription factor", Circulation 102, 2255–2261.
  • Walder, C.E. Errett, C.J. Bunting, S., Lindquist, P., Ogez, J.R. Heinsohn, H.G. Ferrara, N. and Thomas, G.R. (1996) "Vascular endothelial growth factor augments muscle blood flow and function in a rabbit model of chronic hind limb ischemia", J. Cardiovasc. Pharmacol. 27, 91–98.
  • Witzenbichler, B., Asahara, T., Murohara, T., Silver, M., Spyridopoulos, I., Magner, M., Principe, N., Kearney, M., Hu, J-S. and Isner, J.M. (1998) "Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting ofissue ischemia", Am. J. Pathol. 153, 381–394.
  • Yang, H.T. Deschenes, M.R. Ogilvie, R.W. and Terjung, R.L. (1996) "Basic fibroblast growth factor increases collateral blood flow in rats with femoral arterial ligation", Circ. Res. 79, 62–69.
  • Yang, H.T. Feng, Y., Allen, L.A. Protter, A. and Terjung, R.L. (2000) "Efficacy and specificity of bFGF increased collateral flow in experimental peripheral arterial insufficiency", Am. J. Physiol. Heart Circ. Physiol. 278, H1966-H1973.
  • Yao, S.N. and Kurachi, K. (1992) "Expression of human factor IX in mice after injection of genetically modified myoblast", Proc. Natl Acad. Sci. USA 89, 3357–3361.
  • Yao, S.N. Smith, K.J. and Kurachi, K. (1994) "Primary myoblast-mediated gene transfer: persistent expression of human factor IX in mice", Gene. Ther. 1, 99–107.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.